Cargando…

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study

BACKGROUND: The Neutrophil to lymphocyte ratio (NLR) has prognostic value in patients with a variety of cancers. However, its prognostic significance in oral squamous cell carcinoma (OSCC) patients has not been fully explored. The purpose of this study was to determine the clinical significance of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakashima, Hikaru, Matsuoka, Yuichiro, Yoshida, Ryoji, Nagata, Masashi, Hirosue, Akiyuki, Kawahara, Kenta, Sakata, Junki, Arita, Hidetaka, Hiraki, Akimitsu, Nakayama, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728793/ https://www.ncbi.nlm.nih.gov/pubmed/26812901 http://dx.doi.org/10.1186/s12885-016-2079-6

Ejemplares similares

Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method
por: Yoshida, Ryoji, et al.
Publicado: (2020)

Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia
por: Sakata, Junki, et al.
Publicado: (2017)

Re-evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice
por: Gohara, Shunsuke, et al.
Publicado: (2021)

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
por: Sakata, Junki, et al.
Publicado: (2019)

IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
por: Matsuoka, Yuichiro, et al.
Publicado: (2016)

Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy
por: Yoshida, Ryoji, et al.
Publicado: (2020)

The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation
por: Matsuoka, Yuichiro, et al.
Publicado: (2022)

miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma
por: Kawahara, Kenta, et al.
Publicado: (2021)

BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene
por: Yamamoto, Tatsuro, et al.
Publicado: (2020)

Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
por: Sakata, Junki, et al.
Publicado: (2020)

Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis
por: Yamana, Keisuke, et al.
Publicado: (2021)

An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
por: Gohara, Shunsuke, et al.
Publicado: (2022)

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
por: Kawaguchi, Sho, et al.
Publicado: (2022)

Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
por: Yoshida, R, et al.
Publicado: (2014)

Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer
por: Kageyama, Shinya, et al.
Publicado: (2020)

Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
por: Harada, Hiroyuki, et al.
Publicado: (2013)

Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer
por: Toya, Ryo, et al.
Publicado: (2020)

The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells
por: Nakamoto, Masafumi, et al.
Publicado: (2017)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
por: Lee, Soo Jin, et al.
Publicado: (2022)

Extracellular N(6)-isopentenyladenosine (i(6)A) addition induces cotranscriptional i(6)A incorporation into ribosomal RNAs
por: Yakita, Maya, et al.
Publicado: (2022)

The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy
por: Young, Caroline A, et al.
Publicado: (2014)

Successful Chemoradiotherapy for Undifferentiated Malignant Neoplasm Arising from the Left Pulmonary Artery
por: Kumagai, Hozumi, et al.
Publicado: (2014)

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
por: Nagata, M, et al.
Publicado: (2011)

Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy
por: Lino-Silva, Leonardo S., et al.
Publicado: (2016)

Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy
por: Muangwong, Pooriwat, et al.
Publicado: (2023)

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
por: Cox, Samantha, et al.
Publicado: (2017)

GCT-56. ACUTE MYELOID LEUKEMIA FOLLOWING CHEMORADIOTHERAPY FOR INTRACRANIAL GERMINOMA: A CASE REPORT
por: Nakaya, Masato, et al.
Publicado: (2020)

Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
por: Imano, Nobuki, et al.
Publicado: (2020)

Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum
por: Kaneyasu, Yuko, et al.
Publicado: (2019)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Shen, Jinwen, et al.
Publicado: (2017)

Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy
por: Yun, Ji Min, et al.
Publicado: (2023)

Simple Transposition Technique for Microvascular Decompression Using an Expanded Polytetrafluoroethylene “Belt”: Technical Note
por: TANAKA, Yuichiro, et al.
Publicado: (2014)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
por: Katsui, Kuniaki, et al.
Publicado: (2020)

The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
por: Lee, Byung Min, et al.
Publicado: (2018)

Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2017)

Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells
por: Nakamura, Takuya, et al.
Publicado: (2014)

The Role of Pretreatment Serum Neutrophil-to-Lymphocyte Ratio in Hypopharyngeal Cancer Treated with Definitive Chemoradiotherapy: A Pilot Study
por: Kuo, Chin, et al.
Publicado: (2019)

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
por: Li, Ke-Jie, et al.
Publicado: (2019)

Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
por: Liu, Maoxi, et al.
Publicado: (2022)

Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy
por: Tanaka, Yosuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cshcaikjvh1f9251okt86i7ou2